SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRETTI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.145
AS - Asia 11.203
EU - Europa 7.333
SA - Sud America 2.164
AF - Africa 280
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 9
Totale 41.159
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.752
SG - Singapore 4.201
CN - Cina 2.645
IT - Italia 2.543
BR - Brasile 1.688
VN - Vietnam 1.159
HK - Hong Kong 1.073
DE - Germania 984
UA - Ucraina 947
TR - Turchia 715
GB - Regno Unito 506
FI - Finlandia 438
FR - Francia 406
RU - Federazione Russa 366
SE - Svezia 308
PL - Polonia 295
JP - Giappone 265
IN - India 222
ID - Indonesia 194
CA - Canada 174
AR - Argentina 165
MX - Messico 162
BD - Bangladesh 146
NL - Olanda 139
IQ - Iraq 89
ZA - Sudafrica 87
PK - Pakistan 83
ES - Italia 73
EC - Ecuador 71
AT - Austria 68
CO - Colombia 65
VE - Venezuela 64
PH - Filippine 50
BE - Belgio 45
UZ - Uzbekistan 45
CL - Cile 41
AE - Emirati Arabi Uniti 35
MA - Marocco 35
MY - Malesia 33
PY - Paraguay 31
SA - Arabia Saudita 31
KE - Kenya 29
IR - Iran 27
CZ - Repubblica Ceca 23
JO - Giordania 23
AU - Australia 22
CH - Svizzera 22
TN - Tunisia 21
LT - Lituania 20
RO - Romania 20
EG - Egitto 19
KZ - Kazakistan 19
NP - Nepal 19
DZ - Algeria 16
KR - Corea 16
PE - Perù 16
AL - Albania 14
AZ - Azerbaigian 14
ET - Etiopia 14
IE - Irlanda 14
RS - Serbia 14
BO - Bolivia 13
IL - Israele 13
OM - Oman 13
CR - Costa Rica 12
SN - Senegal 12
LB - Libano 11
TH - Thailandia 11
JM - Giamaica 10
PT - Portogallo 10
DO - Repubblica Dominicana 9
EU - Europa 9
SM - San Marino 9
UY - Uruguay 9
BG - Bulgaria 8
BY - Bielorussia 8
AO - Angola 7
HU - Ungheria 7
LY - Libia 7
PS - Palestinian Territory 7
TW - Taiwan 7
DK - Danimarca 6
GE - Georgia 6
HN - Honduras 6
HR - Croazia 6
LV - Lettonia 6
NG - Nigeria 6
EE - Estonia 5
MD - Moldavia 5
CI - Costa d'Avorio 4
CY - Cipro 4
GH - Ghana 4
GT - Guatemala 4
MN - Mongolia 4
NO - Norvegia 4
SI - Slovenia 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BH - Bahrain 3
Totale 41.101
Salva come PNG Salva come JPEG
Città #
Singapore 2.516
Ashburn 2.161
Fairfield 2.120
Woodbridge 1.928
Jacksonville 1.119
Houston 1.077
Hong Kong 1.058
San Jose 1.000
Chandler 945
Seattle 853
Santa Clara 772
Wilmington 725
Cambridge 719
Ann Arbor 696
Beijing 654
Izmir 461
Ho Chi Minh City 406
Nanjing 367
New York 291
Princeton 283
Warsaw 282
Dallas 277
Council Bluffs 266
Hanoi 266
Tokyo 251
Lauterbourg 240
Dearborn 237
Milan 224
Ferrara 213
Los Angeles 213
Helsinki 204
San Diego 176
Bremen 163
Rome 158
São Paulo 141
Boardman 138
Munich 126
Jakarta 123
Nanchang 106
Mexico City 96
Bologna 88
Tianjin 86
Hebei 82
Shanghai 82
Hefei 80
Moscow 77
Falls Church 74
Shenyang 73
Nuremberg 70
Chicago 65
London 63
Buffalo 57
Changsha 56
Rio de Janeiro 56
Frankfurt am Main 55
Haiphong 55
Naples 54
Jiaxing 51
Redwood City 48
Toronto 48
Mountain View 47
Kunming 46
The Dalles 45
Montreal 44
Belo Horizonte 42
Da Nang 42
San Francisco 42
Brooklyn 41
Guangzhou 41
Orem 41
Tashkent 41
Baghdad 40
Orange 40
Brussels 39
Jinan 39
Johannesburg 39
Turku 39
Atlanta 38
Columbus 37
Stockholm 37
Amsterdam 36
Norwalk 36
Turin 36
Vienna 36
Brasília 35
Florence 35
Curitiba 34
Chennai 31
Boston 30
Guayaquil 30
Palermo 30
Zhengzhou 29
Lahore 28
Verona 28
Lappeenranta 27
Manchester 25
Nairobi 24
Phoenix 24
Porto Alegre 24
Ankara 22
Totale 26.791
Salva come PNG Salva come JPEG
Nome #
Mixed odontogenic tumors. Studies on the significance of correlations between ameloblastic fibroma, ameloblastic fibro-odontoma and odontoma 556
Classificazione TNM dei tumori maligni-VIII edizione: Quali novità? 540
Protocollo assistenziale nelle donne a rischio ereditario di tumore della mammella e/o ovaio 500
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) 321
I tumori in Emilia-Romagna 282
Survival of cancer patients in Europe: the EUROCARE study 281
I tumori in Italia, rapporto 2007: sopravvivenza. 273
Characteristics of the colorectal cancers diagnosed in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening [Caratteristiche dei tumori del colon retto diagnosticati in Italia nei primi anni Duemila. Dati dello studio IMPATTO sdelo screening colorettale] 272
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 269
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 256
Classificazione Internazionale delle malattie per l'Oncologia, terza edizione 243
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 238
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 237
Application of quantitative analysis to biologic profile evaluation in breast cancer 223
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 221
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study 221
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting 218
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study 218
Completeness and timeliness: Cancer registries could/should improve their performance 216
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 215
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma 210
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy 209
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 207
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 206
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) 205
Ageing and other factors behind recent cancer incidence and mortality trends in Italy 203
The effect of palliative care on the assistance of terminally ill cancer patients in the Province of Ferrara in 2002 201
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 199
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy 199
I programmi di screening oncologici in Emilia-Romagna. I dati dei seminari regionali 2016 199
An estimate of the number of people in Italy living after a childhood cancer 196
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002 195
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 192
The burden of HPV-related diseases in Italy, 2001-12 192
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) 192
Registro Tumori della provincia di Ferrara 190
Epidemiology of rare cancers and inequalities in oncologic outcomes 190
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 189
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States 189
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours 189
Italy, Ferrara province 188
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89828 children from 198 registries in 53 countries 187
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 186
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes 186
Quantitative immunoprofiles of breast cancer performed by image analysis 185
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 185
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and outside a Network Setting 184
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 183
Classificazione TNM dei tumori maligni, VII edizione 2009. Novità e ricadute pratiche per l’epidemiologia dei tumori. 183
[The contribution of the Italian association of cancer registries (AIRTUM)] 181
The Results of an Italian Quality Assurance Program Support the New American Society for Colposcopy and Cervical Pathology Recommendations for Colposcopy Practice 180
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study 177
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types 177
I tumori in Italia - Rapporto 2012. I tumori dei bambini e degli adolescenti [Italian cancer figures, report 2012: Cancer in children and adolescents] 176
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project 175
Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy 174
Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy 173
International incidence of childhood cancer, 2001-10: a population-based registry study 173
Survival from salivary glands adenoid cystic carcinoma in European populations 173
Treatment challenges in and outside a network setting: Soft tissue sarcomas 173
Survival trends for primary liver cancer, 1995–2009: analysis of individual data for 578,740 patients from 187 population-based registries in 36 countries (CONCORD-2) 173
Cancer prevalence estimates in Europe at the beginning of 2000 172
Screening history of cervical cancers in Emilia-Romagna, Italy: defining priorities to improve cervical cancer screening 172
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 171
Incidence trends of colorectal cancer in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening 171
Aggiornamento della sopravvivenza dei pazienti con tumore in Italia: confronti geografici e focus su pazienti con tumori oggetto di screening, pediatrici e associati al fumo [Update of survival of cancer patients in Italy: geographical comparisons and focus on patients with cancers targeted by screening programmes, childhood cancers, and smoking-associated cancers] 170
The first two years of colorectal cancer screening in Ferrara, Italy 170
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 168
Cancer Incidence in Ferrara Province (1998-2002) 168
Survival of European patients with central nervous system tumors 167
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 166
p53 Expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern, and short-term survival 166
Identifying Ferrara’s elderly people with low influenza immunization rates: the contribution of a local socio-economic deprivation index 166
Estimates of cancer burden in Emilia-Romagna 165
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. 165
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study 164
The burden of rare cancers in Europe 163
Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors 162
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer 162
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects 161
Extension of the target age range of mammography screening programme and governance of mammography practice in the Emilia-Romagna Region (Northern Italy) 161
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 161
National estimates of cancer patients survival in italy: A model-based method 160
Regional inequalities in cancer care persist in Italy and can influence survival 160
Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study 159
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods 159
Cancer incidence and mortality trends from 2003 to 2014 in Italy 159
Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project 157
Changes in cervical cancer incidence following the introduction of organized screening in Italy 157
Estimates of cancer burden in Italy 156
Rare cancers are not so rare: the rare cancer burden in Europe 156
Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade 156
Early (short-interval) rescreen in mammography screening 156
[A comparative analysis between regional mesothelioma registries and cancer registries: results of the ReNaM-AIRTUM project]. 154
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study 154
Treatment challenges in and outside a network setting: Head and neck cancers 154
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe 153
AIRTUM e SIE insieme per una definizione condivisa dei tumori emolinfopoietici [AIRTUM and SIE for a shared definition of haemolymphopoietic cancers] 153
Incidence, survival and prevalence of myeloid malignancies in Europe 152
Incidence and survival of rare urogenital cancers in Europe 152
Totale 19.822
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.693
Totale 193.782
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021604 0 0 0 0 0 0 0 0 0 0 366 238
2021/20222.548 87 295 205 166 129 144 134 195 109 203 188 693
2022/20232.580 312 127 52 266 488 379 61 253 328 34 170 110
2023/20241.426 170 169 60 75 99 125 61 74 44 67 90 392
2024/20255.931 208 147 527 191 728 427 366 401 889 777 686 584
2025/202614.475 1.230 661 1.483 1.800 1.860 852 1.803 925 1.540 1.904 417 0
Totale 41.697